News Conference News ACC 2018 Reversal Agent for Factor Xa Inhibitors Continues to Look Good: ANNEXA-4 Todd Neale March 13, 2018
News Daily News Nephroprotective NOACs? Renal Dysfunction Not Infrequent Among A-fib Patients, but Some Agents Reduce Risk Yael L. Maxwell November 28, 2017
News Conference News TCT 2017 Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used Todd Neale November 02, 2017
News Daily News Preventing Dementia May Be Another Reason to Take Oral Anticoagulants for A-fib Todd Neale October 25, 2017
News Daily News Dabigatran Reversal Agent Yields No Surprises in Final RE-VERSE AD Study Results Todd Neale July 14, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Features Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más Shelley Wood December 30, 2016
News Daily News Oral Anticoagulation Use Common in PCI Patients, With Triple Therapy the Norm at Discharge Todd Neale October 18, 2016
News Daily News Were Problems With the Point-of-Care Device Used in ROCKET AF Kept From the FDA? BMJ Says Yes Todd Neale September 28, 2016
News Daily News FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors Michael O'Riordan August 18, 2016
News Daily News FDA: No More Chances for Embattled Coagulation Monitoring System Todd Neale July 13, 2016
News Daily News FDA: No Más Oportunidades para el Acosado Sistema para Monitorizar la Coagulación Todd Neale July 13, 2016
News Daily News ROCKET AF Investigators Respond to New Questions About Point-of-Care Warfarin Monitoring Device Todd Neale July 08, 2016
News Daily News Sin Dinero Ni Medicamentos: Barreras Globales a la Prevención Secundaria de la Enfermedad Cardiovascular Caitlin E. Cox October 27, 2015
News Daily News No Money, No Drugs: Global Barriers to Secondary CVD Prevention Caitlin E. Cox October 27, 2015